PACS Group Overstated 1Q, 2Q Revenue

Dow Jones
Jun 17

By Katherine Hamilton

PACS Group said it overstated its revenue for the three months ended on March 31, 2024, and the three and six months ended on June 30, 2024, and will be restating results from those periods.

The holding company, which invests in post-acute healthcare facilities, said Monday it overstated its total revenue by $15 million to $17 million in the quarter ended March 31, 2024, and by $46 million to $48 million in the quarter ended June 30, 2024.

The prior financial statements for those periods should not be relied upon, PACS said.

Revenue from respiratory services and certain other therapy services billed under Medicare Part B should not have been recognized as revenue in the two quarters, PACS said.

PACS said in November of last year an independent audit committee and external counsel were conducting an investigation of third-party allegations. The audit committee is nearing completion of the investigation and has found no basis to question the integrity of PACS's executive team, it said Monday.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

June 16, 2025 16:40 ET (20:40 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10